A Study to Describe a Group of Spanish Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on Quality of Life

Novartis

Status: Completed

Conditions: Familial Mediterranean Fever

Study type: Observational

Funder types: Industry

Identifiers

NCT06923124

CACZ885NES01R

Details and patient eligibility

About

A retrospective, non-interventional, single-center study conducted in Spain, based on the collection of data from the medical histories of patients with Familial Mediterranean fever (FMF) diagnosed during childhood from January 2005 to December 2021.

Data from the patients' medical records was collected retrospectively, from the time of diagnosis to the current moment of the patient's enrollment in the study. Patients had a minimum follow-up of 3 months after diagnosis.

Enrollment: 44 patients

Sex: All

Ages: Under 28 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients with FMF clinically and/or genetically diagnosed during childhood according to the site's clinical practice.
2. Patients with at least 3 months of follow-up from the date of diagnosis, at the time of their enrollment in the study.

Exclusion criteria

1. Patients with autoinflammatory disease excluding FMF.
2. Patients with recurrent fever of another etiology (infectious, tumor or other).

Trial design

44 participants in 1 patient group

FMF Cohort

Description:

Spanish patients diagnosed with FMF during childhood from January 2005 to December 2021.